INDIANAPOLIS and CAMBRIDGE, Mass., March 15, 2018 -- hc1.com®, the leader in healthcare relationship management, and Ovation.io, Inc. (Ovation), makers of the fastest-growing clinical laboratory information (LIMS) and commercialization platform, today announced a platform integration that gives small, specialized testing laboratories access to powerful LIMS, client relationship and analytics solutions. The integration will allow these labs to grow their businesses, in addition to creating new tools to partner with payers, providers and researchers. [Click to tweet.]
The integrated solutions deliver robust features on par with more expensive enterprise solutions that are out of reach for many startups and small labs.
“There is a tremendous amount of innovation happening at startups and small labs, especially in the genetic and molecular testing areas. This integration levels the playing field by providing affordable access to world-class LIMS and analytics solutions needed to grow their businesses and compete with larger labs,” said Brad Bostic, chairman and CEO of hc1.com.
Ovation’s cloud-based LIMS is an out-of-the box solution for clinical diagnostics labs that scales to accommodate the needs of labs for sample tracking, billing and reimbursement, reporting, document management, training management, client management, laboratory consulting services and business analytics. hc1.com's live analytics enables lab managers to immediately visualize healthcare data in real-time dashboards for an instant view of performance. With this integration, joint customers have access to a number of standardized reports that give insight on quality metrics, as well as financial and sales performance.
“As Ovation continues to reimagine what a LIMS should be, integrating with best-in-class partners is key to our commercialization ecosystem and to our mission of helping our customers change the role of the diagnostic lab in clinical care, research and development,” said Barry Wark, CEO of Ovation. “Small labs will be able to participate in research and real world evidence collaborations at earlier stages and share data and assets that are unique to emerging labs.”
The Ovation/hc1 integration will be seamless to customers. It is available immediately by contacting [email protected] or [email protected].
About hc1.com
hc1.com®, the leader in healthcare relationship management, is passionate about unlocking the answers that solve critical healthcare challenges. hc1 has been adopted across more than 1,000 lab, post acute care, and health system locations, including Cleveland Clinic, Abbott, Nationwide Children’s Hospital and Sonic Healthcare. The company has received accolades from Gartner Research, was named "Best Healthcare CRM" by Frost & Sullivan and is the top rated solution in the KLAS Healthcare CRM report. Follow us on Twitter @hc1_HRM, LinkedIn, and Facebook.
About Ovation
Ovation is a scientific data company providing a cloud-based laboratory information system for Clinical Diagnostics that focuses on addressing challenges in the critical functional areas of Lab Management, Business Management, and Relationship Management. Beyond standard sample and workflow tracking, Ovation is reimagining the central role a LIMS or LIS plays in the overall ecosystem of a clinical diagnostics laboratory. Using a modern infrastructure with seamless integrations of best-in-class partners and consultants, Ovation provides labs with an out-of-the box laboratory management experience that scales with each individual lab’s needs. Ovation’s flagship product, Ovation Diagnostic, is the central component of this rapidly expanding laboratory commercialization platform. More information at www.ovation.io. Follow us on Twitter @ovation_io.
For information, contact:
For hc1.com:
Linda Muskin, 847-432-7300
[email protected]
For Ovation:
Eleanor Maillie, 978-879-9244
[email protected]


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



